Propranolol for Infantile Haemangiomas: Experience from a Tertiary Center

AIM: Infantile haemangiomas are the most common tumor of infancy. We report the use of propranolol for treatment of problematic and complicated haemangiomas. PATIENTS AND METHODS: Propranolol was given to 52 children with mean age of 18.2 months at onset of treatment. After clinical and electrocardi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandey, Vaibhav, Tiwari, Preeti, Gangopadhyay, Ajay N, Gupta, Dinesh K, Sharma, Shiv P, Kumar, Vijayendar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996789/
https://www.ncbi.nlm.nih.gov/pubmed/24761098
http://dx.doi.org/10.4103/0974-2077.129975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996789/
https://www.ncbi.nlm.nih.gov/pubmed/24761098
http://dx.doi.org/10.4103/0974-2077.129975

Ejemplares similares